inkt cells
Cell therapyexperimental
Clinical trial activity
11 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2017 (NCT03093688)
Timeline
Indications
Studied for
- Adenocarcinoma · Phase 2
- Carcinoma, Hepatocellular · Phase 2/Phase 3
- Carcinoma, Non-Small-Cell Lung · Phase 1/Phase 2
- Carcinoma, Renal Cell · Phase 1/Phase 2
- Esophageal Neoplasms · Phase 2
- Leukemia, Myeloid, Acute · Early Phase 1
- Multiple Myeloma · Phase 1
- Neoplasms · Phase 1
- Pancreatic Neoplasms · Phase 1/Phase 2
- Respiratory Distress Syndrome · Phase 1
- Small Cell Lung Carcinoma · Phase 1/Phase 2
- Stomach Neoplasms · Phase 2
Mechanism of action
- Natural killer cellSupplementation
Natural killer cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- inkt cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07055568 | N/A | Sep 30, 2025 | Jiao Tong University |
| NCT06747832 | Early Phase 1 (Phase 1) | Dec 15, 2024 | Government of China, Weifang People's Hospital |
| NCT06702098 | Early Phase 1 (Phase 1) | Nov 25, 2024 | Government of China, Guangzhou Medical University |
| NCT06251973 | Phase 2 | Feb 1, 2024 | Memorial Sloan-Kettering Cancer Center |
| NCT05962450 | Phase 2 | Aug 1, 2023 | Capital Medical University, Government of China |
| NCT05108623 | Phase 1 | Nov 30, 2021 | MiNK Therapeutics |
| NCT04754100 | Phase 1 | Mar 29, 2021 | Agenus Inc. |
| NCT04582201 | Phase 1 | Sep 21, 2020 | Agenus Inc., MiNK Therapeutics |
| NCT04011033 | Phase 2/Phase 3 (Phase 3) | Mar 1, 2019 | Capital Medical University |
| NCT03175679 | Phase 1 | May 1, 2017 | Capital Medical University |
| NCT03093688 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2017 | Fudan University |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 3 | 3 | 3 | 2017 |
| Government of China | Government | 3 | 2 | 2 | 2023 |
| Agenus Inc. | For profit | 2 | 1 | 1 | 2020 |
| MiNK Therapeutics | For profit | 2 | 2 | 1 | 2020 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Guangzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Weifang People's Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
9 organizations
Page 1 / 1